№ files_lp_4_process_1_49772
File format: docx
Character count: 1490
File size: 20 KB
Clinical genetics consultation plan outlining medical history review, differential diagnosis, counseling topics, and proposed genetic testing for a patient with recurrent first-trimester pregnancy loss.
Patient Name:
Emma Smith
Age:
29
Biological Sex:
Female
Gender:
Female
Gravida/Para Status:
G4P0040
Appointment Time:
1:00 PM – 1:30 PM
Patient Status:
New Patient
Clinical Indication:
Recurrent pregnancy loss with four first-trimester miscarriages
Referral Specialty:
Adult Genetics
Relevant Medical Care:
OB/GYN, Allergy and Immunology, Pulmonology
Known Medical Conditions:
Severe nut allergy, asthma
Previous Genetic Testing:
Natera Horizon carrier screening reportedly negative for patient and partner
Family History Status:
Not formally collected
Prior Specialist Evaluation:
No previous genetics consultation; not previously evaluated by reproductive endocrinology and infertility
Differential Diagnosis:
Fetal chromosomal abnormality, parental chromosomal abnormality, uterine abnormalities, hormonal disorders, blood clotting abnormalities
Planned Evaluations:
Collection of family and medical history, targeted pregnancy history questions, assessment of prior products of conception testing
Proposed Genetic Testing:
Karyotype analysis for patient and reproductive partner
Counseling Topics:
Genetics education including genes, chromosomes, and translocations; psychosocial counseling regarding recurrent pregnancy loss
Consent Process:
Informed consent discussion including benefits, limitations, and possibility of incidental findings
Clinical Objective:
Evaluation of potential genetic causes of recurrent miscarriage and support for reproductive decision-making
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
Greater Manchester
Topic:
Delirium care, Clinical observer-ship
Document type:
Evaluation report
Organ / Institution:
Dementia United, NHS Greater Manchester Integrated Care
Author:
Helen Pratt, Professor Emma Vardy
Target Audience:
Healthcare professionals, policymakers
Period of activity:
February to March 2025
Approval Date:
October 2025
Date of changes:
N/A
Year:
2022
Region / City:
Maryland
Topic:
Commercial Off-the-Shelf Software Procurement
Document Type:
Procurement Request for Proposal (PORFP)
Agency:
Maryland Department of General Services
Author:
Maryland Government
Target Audience:
Authorized COTS Software Master Contractors
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Fresno County, California
Theme:
Managed care, behavioral health services, provider transition
Document type:
Policy update, provider communication
Organization / Institution:
Department of Behavioral Health (DBH)
Author:
Department of Behavioral Health (DBH)
Target Audience:
Individual/Group Providers
Period of Validity:
From July 1, 2023, to June 30, 2024
Approval Date:
June 20, 2023
Date of Changes:
June 20, 2023
Purpose:
To communicate updates regarding CalAIM and Payment Reform to individual/group providers
MCO Module:
SmartCare
Payment Rates:
Varies by provider type, license, and service type
Training Dates:
May 4, May 11, June 1, 2023
Testing & Approval:
Required for MCO Module
CMS 1500 Forms:
Continuation until further notice
Contract Extension:
12-month extension from July 1, 2023, to June 30, 2024
Amendment:
Agreement No. 20-236BOS
Q&A Section:
Available online
Transportation:
Managed Care Plan responsibilities
Questions Contact:
[email protected]
CPT Coding Queries:
[email protected]
Additional Resources:
DHCS library
Service Agreement:
Questions regarding contract differences addressed
Service and Travel Time:
Policies on documentation and travel time for claims processing
Year:
2026
Institution:
University of KwaZulu-Natal
Scholarship Name:
Emma Smith Overseas Scholarship
Document Type:
Scholarship Conditions and Application Form
Reference:
30/33/5
Closing Date:
13 March 2026
Eligibility:
Female South African graduates resident in Durban for at least three years
Citizenship Requirement:
South African citizens
Age Requirement:
Under 25 years on 1 January of the year of award unless otherwise determined by Senate
Study Level:
Advanced or postgraduate studies overseas
Duration of Scholarship:
Two years full-time
Awarding Authority:
Senate of the University of KwaZulu-Natal
Submission:
Financial Aid Advisor on respective campus
Campuses:
Edgewood; Howard; Medical School; PMB; Westville
Required Documents:
Curriculum Vitae; Full Academic Record; Two Reference Letters; Proof of Contact with Foreign Institution; Letter of Motivation; Proof of Residence; Proof of Identity
Year:
Not specified
Subject:
Creative Writing; English Language and Literature
Topic:
Script writing and adaptation from prose to film script
Document type:
Educational worksheet
Educational level:
A Level
Educational board:
WJEC
Source work:
Emma (1815)
Original author of source text:
Jane Austen
Lesson:
Lesson 2
Course / resource:
Creative Writing 1 digital blended learning resource
Activity type:
Reading analysis and scriptwriting exercise
Setting of source extract:
Box Hill picnic scene
Characters referenced:
Emma Woodhouse; Frank Churchill; Miss Bates; Mr Knightley
Purpose:
Analysis of narrative description and dialogue for adaptation into a film script
Instructions included:
Identification of narrative features and creation of a script from a literary extract
Year:
Not specified
Region / City:
Newcastle, West
Theme:
Sports, Community Engagement
Document Type:
Personal Profile
Organization / Institution:
Hat-Trick Charity, St Johns Primary School
Author:
Emma Brown
Target Audience:
General public, local community
Period of Activity:
2009 - present
Approval Date:
Not specified
Date of Changes:
Not specified
Date of Birth:
31 Mar 1853
Place of Birth:
Ohio City
Date of Death:
1 Jul 1933
Place of Death:
Wabash, Adams, Indiana, USA
Date of Death Registration:
1933
Father:
Thomas Patterson
Mother:
unknown
Spouse:
Wm Rawley
Informant:
Thomas T Rawley
Burial:
Crawford Cemetery, 7-3-1933
Gender:
Female
Race:
White
Age:
80y 3m
Marital Status:
Widowed
Position:
Account Manager
Company:
CCS Insight
Previous Experience:
Cannes Lions International Festival of Creativity
Education:
BA in Film and Television Production, University of West London
Area of Expertise:
Marketing, Events, Social Media Management, PR
Key Clients:
Netflix, Spotify, Oppo, Epic Games
Date Joined CCS Insight:
Late 2021
Context:
Profile of Emma Hoare, detailing her role at CCS Insight and previous work experience.
Year:
2028
Award:
Emma Castelnuovo Award
Type of document:
Nomination form
Subject:
Mathematics education
Nominee type:
Individual or small team
Required attachments:
Summary statement, work description, detailed account, curricula vitae, publications, support letters, contact information
Submission deadline:
November 30, 2026
Recipient:
Chair of the Emma Castelnuovo Award Committee, Professor Kaye Stacey
Format:
Electronic submission via e-mail
Protocol version:
6.0
Date:
18 September 2020
Study name:
rEECur
Study design:
International randomised controlled trial
Medical condition:
Recurrent and primary refractory Ewing sarcoma
Intervention:
Chemotherapy
Sponsor:
University of Birmingham
Sponsor protocol number:
RG_13-277
CRCTU number:
SA2015
EudraCT number:
2014-000259-99
ISRCTN reference number:
ISRCTN36453794
Chief Investigator:
Dr Martin McCabe
Coordinating institution:
Cancer Research UK Clinical Trials Unit, University of Birmingham
Geographic scope:
International
Participating regions:
United Kingdom, Germany, Italy, France, Spain, Scandinavia, Australia, New Zealand, Switzerland
Target population:
Patients with recurrent or primary refractory Ewing sarcoma
Regulatory status:
Ethics and regulatory approval required per participating country
Amendment history:
Substantial amendments between 2014 and 2016
Document type:
Clinical trial protocol
Randomisation method:
Centralised online randomisation
Trial phase:
Phase II (Germany-specific limitation noted)
Year:
2024
Region / city:
Global
Theme:
Oncology, Endometrial Cancer, Pharmaceutical Submissions
Document Type:
Medical Submission
Organization / Institution:
AstraZeneca Pty Ltd
Author:
AstraZeneca Pty Ltd
Target Audience:
Medical professionals, regulatory bodies, pharmaceutical companies
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2022
Country:
Australia
Therapeutic area:
Oncology
Disease:
Endometrial cancer
Biomarker status:
Mismatch repair deficient (dMMR)
Medicine name:
Dostarlimab
Brand name:
Jemperli
Dosage form:
Solution concentrate for intravenous infusion
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Regulatory body:
Pharmaceutical Benefits Advisory Committee
Submission type:
Standard Re-entry submission
Requested listing:
Section 100
Comparator treatments:
Standard of care chemotherapy; pembrolizumab plus lenvatinib; pembrolizumab monotherapy
Clinical trial referenced:
GARNET
Approval status:
Provisional approval
Indication:
Recurrent or advanced endometrial cancer after platinum-containing regimen
Decision context:
PBS listing consideration
Period covered:
Up to November 2022
Year:
2023
Region / city:
Aarhus, Denmark
Topic:
Psychiatry, Genetics
Document Type:
Research Supplement
Institution:
iPSYCH Research Initiative, Aarhus University
Author:
iPSYCH Investigators
Target Audience:
Researchers, Geneticists, Psychiatrists
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / city:
United States
Theme:
Gastrointestinal pharmacology, infectious diseases, antibiotic resistance, healthcare management
Document Type:
Review
Institution:
Hackensack Palisades Medical Center, Augusta University
Author:
Nagesh VK, Tran HHV, Elias D, Kianifar Aguilar I, Sethi T, Menon A, Mansour C, Furman F, Tsotsos K, Subar T, Auda A, Sidiqui A, Lamar J, Wadhwani N, Dey S, Lo A, Atoot A, Weissman S, Sifuentes H, Bangolo AI
Target Audience:
Healthcare professionals, researchers, medical practitioners
Period of Validity:
Ongoing studies, review is relevant until new treatments emerge
Date of Approval:
2024-07-25
Date of Changes:
2024-07-21
Year:
2021
Region / City:
Not specified
Theme:
Health, Medicine
Document Type:
Medical Guidance
Organization:
Not specified
Author:
Not specified
Target Audience:
Patients on long-term steroid therapy
Period of Validity:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
Chongqing, Hong Kong
Topic:
Chemical dynamic modeling, Neural networks, Attention mechanisms
Document Type:
Research article
Institution:
Chongqing University, Chongqing Technology and Business University, The Hong Kong Polytechnic University
Authors:
Yue Li, Ning Li, Jingzheng Ren, Weifeng Shen
Target Audience:
Researchers in chemical engineering, machine learning, and neural networks
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Context:
A research article on a neural network architecture (LACG) for modeling chemical dynamic processes with high accuracy.
Country:
Nigeria
Period Covered:
1981–2023
Subject:
Economic Growth and Recurrent Public Expenditure on Roads and Construction
Type of Document:
Academic Research Paper
Data Sources:
Central Bank of Nigeria Reports
Methodology:
Autoregressive Distributed Lag (ARDL) Model and Bounds Test
Variables Examined:
Real Gross Domestic Product, Recurrent Expenditure on Roads and Construction, Interest Rate, Inflation Rate
Keywords:
Economic Growth, Recurrent Expenditure, ARDL, Road and Construction
Sector Focus:
Transport Infrastructure and Public Finance
Geographical Scope:
National
Analytical Approach:
Long-run and Short-run Econometric Analysis
Time References Mentioned:
1981, 1990, 1999, 2006, 2015, 2016, 2017, 2018, 2019, 2023
Year:
2019
Region / City:
United Kingdom
Topic:
Psychological support for recurrent miscarriage
Document type:
Research study
Institution:
Not specified
Author:
Bailey et al.
Target audience:
Women with recurrent miscarriage, healthcare professionals, researchers
Period of validity:
Not applicable
Approval date:
Not specified
Date of changes:
Not specified
Year:
2016
Region / City:
Unknown
Topic:
Medical research, Pediatric Intensive Care Unit (PICU), mortality prediction
Document Type:
Research article
Organization / Institution:
Unspecified
Author:
M. Aczon, D. Ledbetter, E. Laksana, L. Ho, R. Wetzel
Target Audience:
Medical researchers, healthcare professionals
Period of Validity:
2016 onwards
Approval Date:
Unknown
Date of Changes:
Unknown
Journal:
World Journal of Gastrointestinal Oncology
Manuscript Number:
80135
Manuscript Type:
Review
Authors:
Ying-Zhe Luo; Hong Zhu
Author Affiliations:
Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
Corresponding Author:
Hong Zhu
Funding:
The Key Research Projects of Science and Technology of Sichuan Province (No. 2022YFS0189)
Received:
September 18, 2022
Revised:
February 11, 2023
Accepted:
February 27, 2023
Published Online:
March 15, 2023
Volume and Issue:
Volume 15, Issue 3
Pages:
405-424
DOI:
10.4251/wjgo.v15.i3.405
Publisher:
Baishideng Publishing Group Inc.
Keywords:
Recurrent hepatocellular carcinoma; Immunotherapy; Immune checkpoint inhibitor; Chimeric antigen receptor-engineered T cell; Oncolytic virus; Tumor vaccine
Subject Area:
Oncology; Hepatology; Cancer Immunotherapy
Geographic Context:
Global epidemiology with reference to East and South-East Asia, United States, and Europe